<div id="readability-page-1"><div><p>(MT Newswires) -- Health care stocks were mixed Friday afternoon, with the NYSE Health Care Index easing 0.01% and the Health Care Select Sector SPDR Fund (XLV) adding 0.1%.</p><p> The iShares Biotechnology ETF (IBB) was shedding 0.5%.</p><p> In corporate news, Amgen's (AMGN) Uplizna has received a positive opinion from the European Medicines Agency's human medicines committee recommending its approval for adults with active immunoglobulin G4-related disease, a rare autoimmune disorder with no authorized treatments in the EU. Amgen shares rose past 3%.</p><p> InterCure (INCR) shares were down 1.4% after it said Friday it has agreed to buy medical cannabis brand and technology company Botanico, also known as ISHI, in a two-phase deal valued at about 10% of InterCure's outstanding shares on a fully-diluted basis.</p><p>ARS Pharmaceuticals (SPRY) shares added nearly 1% after the company said its nasal spray Neffy has received regulatory approval in Japan for the emergency treatment of allergic reactions, including anaphylaxis.</p></div></div>

SPRY

<p>Health care stocks showed mixed performance on Friday, with the NYSE Health Care Index down 0.01% and the Health Care Select Sector SPDR Fund up 0.1%. Amgen's Uplizna received a positive opinion for approval in the EU, boosting its shares by over 3%. InterCure's shares fell 1.4% after announcing a deal to acquire Botanico. Meanwhile, ARS Pharmaceuticals' shares rose nearly 1% following regulatory approval for its nasal spray Neffy in Japan.</p>

Sector Update: Health Care Stocks Mixed Friday Afternoon